Resistance to Targeted Therapies in HER2+ Breast Cancers: Models, Mechanisms, and Treatment Implications
Rachel Schiff, PhD
Professor, Lester & Sue Smith Breast Center
Departments of Medicine and Molecular and Cellular Biology
Baylor College of Medicine Houston, TX

Hosted by: Hanna Irie, MD, PhD